BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6237852)

  • 1. [Clinical aspects of polycystic syndrome of the ovary: the behavior of salivary testosterone and estrone].
    Piccione E; Baschieri L; Giacomello F; Sesti F
    Clin Ter; 1984 Jul; 110(2):119-22. PubMed ID: 6237852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma and salivary steroids in the differential diagnosis of hirsutism. Use of mathematical technics for individualizing the most useful parameters].
    Balsamo A; Armanino C; Cenderelli G; Migliardi M; Mezzanotte M; Grassi G; Lanteri S; Massobrio M; De Filippis V
    Minerva Endocrinol; 1987; 12(3):217-22. PubMed ID: 3657742
    [No Abstract]   [Full Text] [Related]  

  • 3. Polycystic ovarian disease--current concepts.
    Biggs JS
    Aust N Z J Obstet Gynaecol; 1981 Feb; 21(1):26-36. PubMed ID: 6789815
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of salivary testosterone in hirsutism].
    Villabona C; Navarro MA; Montaña E; Bonnin R; Soler J
    Med Clin (Barc); 1986 Feb; 86(5):183-6. PubMed ID: 3959649
    [No Abstract]   [Full Text] [Related]  

  • 5. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of iatrogenic pseudopregnancy on various hormone levels in the polycystic ovary syndrome. Differences between patients with or without galactorrhea].
    Reid I; Crisosto C; Matus A; Peña M
    Rev Chil Obstet Ginecol; 1979; 44(6):270-9. PubMed ID: 122276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunocytochemical studies of the ovaries in androgenized women (polycystic ovaries, hyperthecosis)].
    Pickartz H; Moltz L; Altenähr E
    Acta Histochem Suppl; 1982; 25():101-5. PubMed ID: 6806855
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison between human urinary follicle-stimulating hormone and human menopausal gonadotropin treatment in polycystic ovary.
    Venturoli S; Paradisi R; Fabbri R; Magrini O; Porcu E; Flamigni C
    Obstet Gynecol; 1984 Jan; 63(1):6-11. PubMed ID: 6419189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Sex steroids and gonadotrophin release in the polycystic ovary syndrome.
    Duignan NM; Shaw RW; Glass MR
    J Obstet Gynaecol Br Commonw; 1974 Dec; 81(12):1004-5. PubMed ID: 4452918
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma catecholamine metabolites and polycystic ovary syndrome.
    Yoshino K; Takahashi K; Nishigaki A; Eda Y; Kitao M
    Asia Oceania J Obstet Gynaecol; 1990 Mar; 16(1):57-62. PubMed ID: 2111696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinaemia in polycystic ovary syndrome.
    Lunde O
    Ann Chir Gynaecol; 1981; 70(4):197-201. PubMed ID: 6797343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polycystic ovary syndrome or Stein-Leventhal syndrome: findings and prospectives].
    Molinatti GM; Limone P
    Minerva Endocrinol; 1987; 12(3):175-8. PubMed ID: 3116378
    [No Abstract]   [Full Text] [Related]  

  • 13. Central opioid activity in polycystic ovary syndrome.
    Lo Dico G; Alongi G; Dones F; Cadili G; Gargano G; Guarneri G; Polito GG
    Panminerva Med; 1987; 29(3):243-8. PubMed ID: 2962058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exploration of the ovarian steroid biosynthetic pathways in the Stein-Leventhal syndrome. Stimulation "in vitro" with HMG].
    Bruni V; Sbiroli C; Forleo R
    Riv Ostet Ginecol; 1967 Feb; 22():Suppl:53-66. PubMed ID: 5601268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis and pathogenesis of polycystic ovary syndrome].
    Lin SQ
    Zhonghua Yi Xue Za Zhi; 1983 Jul; 63(7):447-52. PubMed ID: 6416651
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of pituitary cell populations in rats with induced polycystic ovaries.
    Francou M; Durdos M; Salvetti NR; Baravalle C; Rey F; Ortega HH
    Cells Tissues Organs; 2008; 188(3):310-9. PubMed ID: 18376105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some new thoughts on the Stein-Leventhal syndrome.
    Greenblatt RB; Mahesh VB
    J Reprod Med; 1974 Sep; 13(3):85-8. PubMed ID: 4415831
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
    Vulkov I; Georgiev Ch
    Akush Ginekol (Sofiia); 1982; 21(3):238-43. PubMed ID: 6289691
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contemporary diagnostic criteria for polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2004; 43(3):55-8. PubMed ID: 15341262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.